Otitis media

Anne G M Schilder, Tasnee Chonmaitree, Allan W. Cripps, Richard M. Rosenfeld, Margaretha L. Casselbrant, Mark P. Haggard, Roderick P. Venekamp

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Otitis media (OM) or middle ear inflammation is a spectrum of diseases, including acute otitis media (AOM), otitis media with effusion (OME; glue ear') and chronic suppurative otitis media (CSOM). OM is among the most common diseases in young children worldwide. Although OM may resolve spontaneously without complications, it can be associated with hearing loss and life-long sequelae. In developing countries, CSOM is a leading cause of hearing loss. OM can be of bacterial or viral origin; during colds', viruses can ascend through the Eustachian tube to the middle ear and pave the way for bacterial otopathogens that reside in the nasopharynx. Diagnosis depends on typical signs and symptoms, such as acute ear pain and bulging of the tympanic membrane (eardrum) for AOM and hearing loss for OME; diagnostic modalities include (pneumatic) otoscopy, tympanometry and audiometry. Symptomatic management of ear pain and fever is the mainstay of AOM treatment, reserving antibiotics for children with severe, persistent or recurrent infections. Management of OME largely consists of watchful waiting, with ventilation (tympanostomy) tubes primarily for children with chronic effusions and hearing loss, developmental delays or learning difficulties. The role of hearing aids to alleviate symptoms of hearing loss in the management of OME needs further study. Insertion of ventilation tubes and adenoidectomy are common operations for recurrent AOM to prevent recurrences, but their effectiveness is still debated. Despite reports of a decline in the incidence of OM over the past decade, attributed to the implementation of clinical guidelines that promote accurate diagnosis and judicious use of antibiotics and to pneumococcal conjugate vaccination, OM continues to be a leading cause for medical consultation, antibiotic prescription and surgery in high-income countries.

Original languageEnglish (US)
Article number16063
JournalNature Reviews Disease Primers
Volume2
DOIs
StatePublished - Sep 8 2016
Externally publishedYes

Fingerprint

Otitis Media
Hearing Loss
Suppurative Otitis Media
Ear
Tympanic Membrane
Anti-Bacterial Agents
Ventilation
Otoscopy
Middle Ear Ventilation
Watchful Waiting
Acoustic Impedance Tests
Adenoidectomy
Eustachian Tube
Audiometry
Otitis Media with Effusion
Hearing Aids
Nasopharynx
Acute Pain
Acute Disease
Middle Ear

Keywords

  • Macmillan Publishers Limited
  • part of Springer Nature

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schilder, A. G. M., Chonmaitree, T., Cripps, A. W., Rosenfeld, R. M., Casselbrant, M. L., Haggard, M. P., & Venekamp, R. P. (2016). Otitis media. Nature Reviews Disease Primers, 2, [16063]. https://doi.org/10.1038/nrdp.2016.63

Otitis media. / Schilder, Anne G M; Chonmaitree, Tasnee; Cripps, Allan W.; Rosenfeld, Richard M.; Casselbrant, Margaretha L.; Haggard, Mark P.; Venekamp, Roderick P.

In: Nature Reviews Disease Primers, Vol. 2, 16063, 08.09.2016.

Research output: Contribution to journalArticle

Schilder, AGM, Chonmaitree, T, Cripps, AW, Rosenfeld, RM, Casselbrant, ML, Haggard, MP & Venekamp, RP 2016, 'Otitis media', Nature Reviews Disease Primers, vol. 2, 16063. https://doi.org/10.1038/nrdp.2016.63
Schilder AGM, Chonmaitree T, Cripps AW, Rosenfeld RM, Casselbrant ML, Haggard MP et al. Otitis media. Nature Reviews Disease Primers. 2016 Sep 8;2. 16063. https://doi.org/10.1038/nrdp.2016.63
Schilder, Anne G M ; Chonmaitree, Tasnee ; Cripps, Allan W. ; Rosenfeld, Richard M. ; Casselbrant, Margaretha L. ; Haggard, Mark P. ; Venekamp, Roderick P. / Otitis media. In: Nature Reviews Disease Primers. 2016 ; Vol. 2.
@article{84030ed75614455abb9f71693e1244a8,
title = "Otitis media",
abstract = "Otitis media (OM) or middle ear inflammation is a spectrum of diseases, including acute otitis media (AOM), otitis media with effusion (OME; glue ear') and chronic suppurative otitis media (CSOM). OM is among the most common diseases in young children worldwide. Although OM may resolve spontaneously without complications, it can be associated with hearing loss and life-long sequelae. In developing countries, CSOM is a leading cause of hearing loss. OM can be of bacterial or viral origin; during colds', viruses can ascend through the Eustachian tube to the middle ear and pave the way for bacterial otopathogens that reside in the nasopharynx. Diagnosis depends on typical signs and symptoms, such as acute ear pain and bulging of the tympanic membrane (eardrum) for AOM and hearing loss for OME; diagnostic modalities include (pneumatic) otoscopy, tympanometry and audiometry. Symptomatic management of ear pain and fever is the mainstay of AOM treatment, reserving antibiotics for children with severe, persistent or recurrent infections. Management of OME largely consists of watchful waiting, with ventilation (tympanostomy) tubes primarily for children with chronic effusions and hearing loss, developmental delays or learning difficulties. The role of hearing aids to alleviate symptoms of hearing loss in the management of OME needs further study. Insertion of ventilation tubes and adenoidectomy are common operations for recurrent AOM to prevent recurrences, but their effectiveness is still debated. Despite reports of a decline in the incidence of OM over the past decade, attributed to the implementation of clinical guidelines that promote accurate diagnosis and judicious use of antibiotics and to pneumococcal conjugate vaccination, OM continues to be a leading cause for medical consultation, antibiotic prescription and surgery in high-income countries.",
keywords = "Macmillan Publishers Limited, part of Springer Nature",
author = "Schilder, {Anne G M} and Tasnee Chonmaitree and Cripps, {Allan W.} and Rosenfeld, {Richard M.} and Casselbrant, {Margaretha L.} and Haggard, {Mark P.} and Venekamp, {Roderick P.}",
year = "2016",
month = "9",
day = "8",
doi = "10.1038/nrdp.2016.63",
language = "English (US)",
volume = "2",
journal = "Nature Reviews Disease Primers",
issn = "2056-676X",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Otitis media

AU - Schilder, Anne G M

AU - Chonmaitree, Tasnee

AU - Cripps, Allan W.

AU - Rosenfeld, Richard M.

AU - Casselbrant, Margaretha L.

AU - Haggard, Mark P.

AU - Venekamp, Roderick P.

PY - 2016/9/8

Y1 - 2016/9/8

N2 - Otitis media (OM) or middle ear inflammation is a spectrum of diseases, including acute otitis media (AOM), otitis media with effusion (OME; glue ear') and chronic suppurative otitis media (CSOM). OM is among the most common diseases in young children worldwide. Although OM may resolve spontaneously without complications, it can be associated with hearing loss and life-long sequelae. In developing countries, CSOM is a leading cause of hearing loss. OM can be of bacterial or viral origin; during colds', viruses can ascend through the Eustachian tube to the middle ear and pave the way for bacterial otopathogens that reside in the nasopharynx. Diagnosis depends on typical signs and symptoms, such as acute ear pain and bulging of the tympanic membrane (eardrum) for AOM and hearing loss for OME; diagnostic modalities include (pneumatic) otoscopy, tympanometry and audiometry. Symptomatic management of ear pain and fever is the mainstay of AOM treatment, reserving antibiotics for children with severe, persistent or recurrent infections. Management of OME largely consists of watchful waiting, with ventilation (tympanostomy) tubes primarily for children with chronic effusions and hearing loss, developmental delays or learning difficulties. The role of hearing aids to alleviate symptoms of hearing loss in the management of OME needs further study. Insertion of ventilation tubes and adenoidectomy are common operations for recurrent AOM to prevent recurrences, but their effectiveness is still debated. Despite reports of a decline in the incidence of OM over the past decade, attributed to the implementation of clinical guidelines that promote accurate diagnosis and judicious use of antibiotics and to pneumococcal conjugate vaccination, OM continues to be a leading cause for medical consultation, antibiotic prescription and surgery in high-income countries.

AB - Otitis media (OM) or middle ear inflammation is a spectrum of diseases, including acute otitis media (AOM), otitis media with effusion (OME; glue ear') and chronic suppurative otitis media (CSOM). OM is among the most common diseases in young children worldwide. Although OM may resolve spontaneously without complications, it can be associated with hearing loss and life-long sequelae. In developing countries, CSOM is a leading cause of hearing loss. OM can be of bacterial or viral origin; during colds', viruses can ascend through the Eustachian tube to the middle ear and pave the way for bacterial otopathogens that reside in the nasopharynx. Diagnosis depends on typical signs and symptoms, such as acute ear pain and bulging of the tympanic membrane (eardrum) for AOM and hearing loss for OME; diagnostic modalities include (pneumatic) otoscopy, tympanometry and audiometry. Symptomatic management of ear pain and fever is the mainstay of AOM treatment, reserving antibiotics for children with severe, persistent or recurrent infections. Management of OME largely consists of watchful waiting, with ventilation (tympanostomy) tubes primarily for children with chronic effusions and hearing loss, developmental delays or learning difficulties. The role of hearing aids to alleviate symptoms of hearing loss in the management of OME needs further study. Insertion of ventilation tubes and adenoidectomy are common operations for recurrent AOM to prevent recurrences, but their effectiveness is still debated. Despite reports of a decline in the incidence of OM over the past decade, attributed to the implementation of clinical guidelines that promote accurate diagnosis and judicious use of antibiotics and to pneumococcal conjugate vaccination, OM continues to be a leading cause for medical consultation, antibiotic prescription and surgery in high-income countries.

KW - Macmillan Publishers Limited

KW - part of Springer Nature

UR - http://www.scopus.com/inward/record.url?scp=85000714874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000714874&partnerID=8YFLogxK

U2 - 10.1038/nrdp.2016.63

DO - 10.1038/nrdp.2016.63

M3 - Article

VL - 2

JO - Nature Reviews Disease Primers

JF - Nature Reviews Disease Primers

SN - 2056-676X

M1 - 16063

ER -